Well that's quite a CV.
Market still looking for a price catalyst although the volumes are light and should run on anticipated news flow. Although not happy with the delays am fully aware this almost the norm in the medical space with 3rd party reviews and approvals.
The technology is still way ahead of alternative measurements and still very confident Jack or any potential suitor will have MEB as the first port of call in a field that is globally a massive market.
Ann: Peter Carlisle Appointed as Director, page-2
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
